The Food and Drug Administration (FDA) issued emergency use authorization for three vaccines to protect against COVID-19.  While these long-awaited vaccines have provided tremendous hope for the nation in looking for a pathway out of the pandemic,... Read More
Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

Additional FAQ Released Regarding Recent Practice Acquisitions As you are likely aware, the U.S. Department of Health and Human Services (“DHHS”) has allocated a total of $50 billion in Provider Relief Funds for general distribution to Medicare... Read More
Blogs & Articles | COVID-19 Resources | Healthcare Law | Medicare and Insurance Audits

As a first in the nation, criminal complaints were filed recently in Federal Court in Rhode Island for fraud related to the seeking of more than a half million dollars in loans pursuant to the Coronavirus, Aid, Relief, and Economic Security... Read More
Blogs & Articles | COVID-19 Resources | Employment Matters | Healthcare Law | Healthcare Litigation | Pharmacy Law | White Collar Defense and Government Investigation

By way of Interim Final Rule dated April 24, 2020, the Small Business Administration (“SBA”) issued further agency guidance in connection with borrower eligibility for loans under the CARES Act’s Paycheck Protection Program (“PPP”) (“New... Read More
Blogs & Articles | COVID-19 Resources | Healthcare Law | Pharmacy Law

Last week, the U.S. Department of Health and Human Services ("HHS") announced that all Medicare-participating providers with COVID-19 related losses are eligible for a second round of funding, totaling $20 billion, from the CARES Act-authorized... Read More
COVID-19 Resources | Employment Matters | Healthcare Law | Pharmacy Law